{"id":"W2100839679","doi":"10.1177/1740774512456453","title":"Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: Not a significant barrier to enrollment","year":2012,"lang":"en","type":"article","venue":"Clinical Trials","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Hôpital du Saint-Sacrement; Université de Sherbrooke","funders":"","keywords":"Medicine; Breast cancer; Clinical trial; Subcategory; Cancer; Randomized controlled trial; Informed consent; Internal medicine; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4003835,0.0004490454,0.008850449,0.0002528362,0.0001586363,0.0000909986,0.0002585536,0.0009429698,0.001725102],"category_scores_gemma":[0.5846143,0.0002886416,0.001015581,0.0003114267,0.001215886,0.0001611836,0.0006345448,0.002167482,0.00002731859],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001442476,"about_ca_system_score_gemma":0.0008971893,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003835915,"about_ca_topic_score_gemma":0.00008421577,"domain_scores_codex":[0.9643618,0.02074949,0.0106979,0.001541436,0.001470134,0.001179205],"domain_scores_gemma":[0.5706031,0.4201816,0.001846913,0.001889533,0.0009444333,0.004534369],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7735059,0.004648763,0.01222612,0.0003154722,0.000760223,0.00005608887,0.00133396,7.085249e-7,0.01863382,0.0009798801,0.002305467,0.1852336],"study_design_scores_gemma":[0.9503686,0.003288016,0.02463991,0.001748048,0.001602233,0.00002783281,0.0003771991,0.0004064088,0.004712956,0.007884111,0.004231558,0.0007131163],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9542471,0.003279788,0.0003559188,0.0316454,0.001818837,0.007860398,0.0004857467,0.00005503038,0.0002518163],"genre_scores_gemma":[0.9792424,0.009934053,0.00134962,0.005445082,0.002627474,0.0007939562,0.00001264901,0.00004708971,0.0005476529],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3994321,"threshold_uncertainty_score":0.9999565,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6986174829355115,"score_gpt":0.7053832411292866,"score_spread":0.006765758193775118,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}